Medical data – the catalyst of progress in science and personalized medicine

Session moderated by will discuss the challenges connected with the access to medical data used in scientific research and the introduction of personalised therapies.

  • Why is the access to medical data in biobanking, personalized medicine and biotechnology industry necessary?
  • Who is the owner of medical data of patients collected by public institutions?
  • What are the barriers in collecting medical data by individuals, scientific institutions and innovative entities operating on the health sector?
  • Can digital transformation in healthcare influence the access to medical data and how it can contribute to the development of science and the biotechnology industry?